Related Experiment Video
Updated: Feb 18, 2026
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Potential Risks and Mitigation Strategies During the Conduct of a Clinical Trial: An Industry Perspective
Seema Bhagat1, Vaibhavi Kapatkar1, Sagar Katare1
1Medical Affairs Department, Wockhardt Limited; Wockhardt Towers, Bandra Kurla Complex, Mumbai - 400 051, India.
Background:
Every phase of a clinical trial should be designed in compliance with good clinical practices by following all relevant regulatory guidelines. Patient safety, data integrity and ethics are an integral part of a successful clinical trial which must be considered. Therefore, risk monitoring is an essential tool to identify the risks associated with conduct of any trial. This article is a result of extensive research conducted by a reputed pharmaceutical company to identify the potential stages of risks associated with the conduct phase of trial that could impact the overall quality and safety of a trial.
Methods:
The skillful and experienced team members of a reputed pharmaceutical company involved in conducting clinical trials underwent brainstorming sessions to assess and categorize the risks associated with each stage of conduct phase of a clinical trial. They also developed a mitigation plan based on their experiences, best practices and applicable guidance documents.
Results:
During conduct phase, risks are associated with preparation of site master and trial master file, courier of study supply to site(s) including investigational product prior to site initiation visit, patient recruitment, telephonic monitoring, adverse or serious adverse event monitoring, site monitoring visit(s), collected case report form pages forward to data management vendor, data query clarification and site close-out visit.
Conclusion:
A close working relationship with all the persons associated with the clinical trial, timely monitoring and prospective mitigation planning is required for the conduct of a high quality trial.
Insights
Risk monitoring is essential for clinical trial quality and patient safety. This research identifies risks during trial conduct and offers mitigation strategies for successful trials.
Area of Science:
- Clinical Trials
- Pharmaceutical Research
- Regulatory Compliance
Background:
- Clinical trials require adherence to Good Clinical Practices and regulatory guidelines.
- Patient safety, data integrity, and ethical considerations are paramount in clinical trial design.
- Risk monitoring is crucial for identifying potential issues during trial conduct.
Purpose of the Study:
- To identify potential risks associated with the conduct phase of clinical trials.
- To assess and categorize risks at each stage of the trial conduct phase.
- To develop a risk mitigation plan for clinical trial conduct.
Main Methods:
- Brainstorming sessions with experienced clinical trial professionals.
- Risk assessment and categorization across all stages of trial conduct.
- Development of mitigation plans based on experience and best practices.
Main Results:
- Identified risks in trial conduct include site file preparation, supply courier, patient recruitment, and monitoring.
- Risks extend to adverse event monitoring, site visits, data management, and site close-out.
- Specific risks identified across multiple conduct phase activities.
Conclusions:
- A close working relationship among all trial personnel is vital.
- Timely and proactive monitoring is essential for high-quality clinical trials.
- Prospective risk mitigation planning is a key component of successful trial conduct.
Related Concept Videos
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:28Preclinical Development: Overview
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Pharmaceutical Poisoning: Potential Scenarios